- Anabolism: chemical reactions where substances are synthesised or 'built-up'. For example, the synthesis of hormones, new tissue and antibodies, to name a few.
- Catabolism: chemical reactions where substances are degraded or 'broken down'. For example, the breakdown of food for energy production and the generation of metabolic waste products such as ketones, urea and lactate, to name a few.
- Carbohydrate metabolism: these are usually detected in infancy and cover a vast range of conditions where specific aspects of carbohydrate metabolism are impaired. Energy production in vital organs can be severely compromised. Depending on the exact problem, these conditions are often supported by dietary interventions. Some better-known examples in this category are galactosaemia, lactose intolerance and glycogen storage diseases.
- Amino acid metabolism: these metabolic conditions involve either the synthesis of vital amino acids or impairment of amino acid degradation. These are so many diseases in this category. However, Phenylketonuria (PKU), Homocysteinuria and Maple Syrup Urine disease are some well-known examples. If a vital amino acid is not synthesised, it is unavailable for its many roles within the body. If an amino acid is not degraded correctly, it can build up, causing damage to specific tissues and organs. Dietary interventions are often used to abate the effects of these diseases.
- Organic acid metabolism: these involve the branched-chain amino acids (isoleucine, leucine and valine). If a specific amino acid cannot be broken down, its build-up can lead to academia (dangerously low blood pH) and vital organ damage. Specific dietary interventions are required, and these often commence in infancy.
- Fatty acid metabolism: many enzymes are required to break down fatty acids for energy; a problem with any one of these enzymes is known as an inborn error of lipid (fat) metabolism. Some involve carnitine (which helps transport fatty acids to your mitochondria for energy production), while others prevent correct lipid storage. Yet another vast category.
- Mitochondrial metabolism: these have a huge array of presentations, but ultimately involve impairment of mitochondrial function and ultimately the production of energy as a whole.
- Porphyrin metabolism: porphyrin rings are specific chemical structures found in vital substances such as haeme (predominantly found in red blood cells) and cytochromes (found in mitochondria for energy production and also in hepatic tissue for detoxification). When not synthesised or degraded properly, they are classified as metabolic diseases known as Porphyrias. It is believed that Pyrrole Disorder may belong to this category.
- Purine and pyrimidine metabolism: purines and pyrimidines are essential chemicals produced by the body and contribute to the structure of DNA, RNA and energy molecules such as ATP to name just a few. Defective enzymes governing purine and pyrimidine metabolism affect the normal sequences of human DNA, meaning harmful mutations are common in this group of metabolic diseases.
- Peroxisomal metabolism: peroxisomes are organelles involved in breaking down very-long-chain fatty acids for energy.
- Steroid metabolism: human steroid hormones include oestrogen, progesterone, testosterone, cortisol, and aldosterone. All steroid hormones are derived from cholesterol. Each condition varies, depending on the exact enzyme and hormone involved. Disorders of secondary sexual characteristics, ambiguous genitalia and adrenal insufficiency all come under this category.
- Lysosomal storage diseases. Lysosomes are organelles and can be described as the recycling centre of the cell. Unwanted substances can be converted into useful substances for a cell by lysosomes. Metabolic disorders involving lysosomes result in the accumulation of cellular waste, leading to cellular and organ damage.
- Failure to thrive
- Growth failure
- Developmental delay
- Delayed or precocious puberty
- Ambiguous genitalia
- Seizures
- Cardiac issues: cardiac failure, myocardial infarction and both high and low blood pressure
- Skin: abnormal pigmentation, lack of pigmentation, excess body hair growth
- Some childhood cancers
- Haematological issues: low platelets, low red cell count, splenomegaly and lymphadenopathy
- Diabetes
- Musculoskeletal pain, weakness and cramping
- Congenital malformations, especially involving facial features
Written by Annalies Corse BMedSc, BHSc
References
Fernandes, John; Saudubray, Jean-Marie; Berghe, Georges van den (2013-03-14). Inborn Metabolic Diseases: Diagnosis and Treatment. Springer Science & Business Media. p. 4. ISBN9783662031476
Jorde, et al. 2006. Carbohydrate metabolism. Medical Genetics. 3rd edition. Chapter 7. Biochemical genetics: Disorders of metabolism. pp139-142
Ogier de Baulny H, Saudubray JM (2002). "Branched-chain organic acidurias". Semin Neonatol. 7 (1): 65–74.
Rosemeyer, Helmut (March 2004). "The Chemodiversity of Purine as a Constituent of Natural Products". Chemistry & Biodiversity 1 (3): 361–401.
Mark A. Sperling (25 April 2008). Pediatric Endocrinology E-Book. Elsevier Health Sciences. p. 35.
Vernon, H. (2015). Inborn Errors of Metabolism. Advances in Diagnosis and Therapy. JAMA Pediatrics. 169(8): 778-782







